Aqua Bio Technology ASA (0I8C) Stock Statistics & Valuation Metrics
Total Valuation
Aqua Bio Technology ASA has a market cap or net worth of NOK 68.60M. The enterprise value is NOK 137.99M.
- Market Cap
- NOK 68.60M
- Enterprise Value
- NOK 137.99M
Share Statistics
Aqua Bio Technology ASA has 15,616,175 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 15,616,175
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Aqua Bio Technology ASA’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- ―
- Profits Per Employee
- 731.10K
- Employee Count
- 2
- Asset Turnover
- ―
- Inventory Turnover
- ―
Income Statement
In the last 12 months, Aqua Bio Technology ASA had revenue of ― and earned 1.46M in profits. Earnings per share was ―.
- Revenue
- ―
- Gross Profit
- 0
- Operating Income
- 15.59M
- Pretax Income
- ―
- Net Income
- 1.46M
- EBITDA
- 7.29M
- Earnings Per Share (EPS)
- ―
Stock Price Statistics
- Beta
- -0.07
- 52-Week Price Change
- -79.98%
- 50-Day Moving Average
- 4.94
- 200-Day Moving Average
- 6.03
- Relative Strength Index (RSI)
- 48.80
- Average Volume (3m)
- 126
Important Dates
Aqua Bio Technology ASA upcoming earnings date is Nov 11, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 26, 2026
- Next Earnings Date
- Nov 11, 2026
- Ex-Dividend Date
- ―
Balance Sheet
Aqua Bio Technology ASA has ― in cash and marketable securities with NOK 666.67K in debt, giving a net cash position of ― billion.
- Cash & Marketable Securities
- ―
- Total Debt
- NOK 666.67K
- Net Cash
- ―
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- ―
Analyst Forecast
The average price target for Aqua Bio Technology ASA is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―